Delcath Systems, Inc. (DCTH)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$16.480.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · DCTH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 95.4 | 85.2 | 37.2 | 2.1 | 2.7 | 3.6 | — | — | — | 2.7 | 2.0 | 1.7 | 1.1 | 0.8 | 0.3 | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | 1.7 | 1.1 | 0.8 | 0.3 | — |
| Cost of Revenues | 12.4 | 11.8 | 6.2 | 0.6 | 0.7 | 0.7 | 0.6 | 0.7 | 1.0 | 0.7 | 0.6 | 0.5 | 0.3 | 0.5 | 0.0 | — |
| Gross Profit | 83.1 | 73.4 | 31.0 | 1.4 | 2.0 | 2.9 | 1.0 | 0.9 | 2.4 | 2.0 | 1.4 | 1.3 | 0.8 | 0.3 | 0.3 | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 47.3 | 43.5 | 29.6 | 22.1 | 17.3 | 13.6 | 11.1 | 11.3 | 9.8 | 9.7 | 9.4 | 10.0 | 15.8 | 20.7 | 28.0 | — |
| R&D Expenses | 37.6 | 29.2 | 13.9 | 17.5 | 18.6 | 13.8 | 11.2 | 9.5 | 19.7 | 10.5 | 8.4 | 6.5 | 4.3 | 12.7 | 26.2 | 25.2 |
| Operating Income | (1.8) | 0.7 | (12.4) | (38.2) | (33.9) | (24.5) | (21.3) | (19.9) | (27.1) | (18.2) | (16.4) | (15.2) | (19.3) | (33.0) | (53.9) | (46.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 21.7 | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | 1.3 | 3.5 | (26.4) | (47.7) | (36.5) | (25.6) | (24.2) | (8.9) | (19.2) | (45.1) | (18.0) | (14.7) | — | — | — | — |
| Income Tax Expense | 0.8 | 0.8 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | 24.2 | — | — | — | — | — | — | — | — | — |
| Net Income | 0.5 | 2.7 | (26.4) | (47.7) | (36.5) | (25.6) | (24.2) | (8.9) | (19.2) | (45.1) | (18.0) | (14.7) | (17.4) | (30.3) | (51.9) | (30.9) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.01 | 0.08 | (0.93) | (2.94) | (4.12) | (3.59) | (8.35) | — | (0.72) | — | — | (0.91) | (1.84) | (4.81) | — | — |
| Diluted EPS | 0.01 | 0.07 | (0.93) | (2.94) | (4.12) | (3.59) | (8.35) | — | (0.72) | — | — | (0.91) | (1.84) | (5.10) | — | — |
| Revenue per Share | 2.40 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 35.9 | 35.8 | 28.5 | 16.2 | 8.9 | 7.1 | 2.9 | — | 26.7 | — | — | 16.2 | 9.5 | 6.3 | — | — |
| Diluted Weighted Avg Shares | 39.8 | 39.9 | 28.5 | 16.2 | 8.9 | 7.1 | 2.9 | — | 26.7 | — | — | 16.2 | 9.5 | 6.6 | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (1.8) | 0.7 | (12.4) | (38.2) | (33.9) | (24.5) | (21.3) | (19.9) | (27.1) | (18.2) | (16.4) | (15.2) | (19.3) | (33.0) | (53.9) | (46.5) |
| Effective Tax Rate | 58.8% | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.